Elevance Health Current Ratio 2010-2025 | ELV

Current and historical current ratio for Elevance Health (ELV) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Elevance Health current ratio for the three months ending March 31, 2025 was 1.43.
Elevance Health Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $61.12B $42.70B 1.43
2024-12-31 $58.94B $40.58B 1.45
2024-09-30 $62.85B $42.03B 1.50
2024-06-30 $62.27B $41.81B 1.49
2024-03-31 $60.95B $44.33B 1.38
2023-12-31 $60.03B $41.79B 1.44
2023-09-30 $61.19B $43.34B 1.41
2023-06-30 $59.74B $41.57B 1.44
2023-03-31 $59.82B $41.89B 1.43
2022-12-31 $55.62B $39.70B 1.40
2022-09-30 $55.60B $41.29B 1.35
2022-06-30 $53.66B $39.31B 1.37
2022-03-31 $53.90B $39.73B 1.36
2021-12-31 $51.12B $34.89B 1.47
2021-09-30 $51.90B $35.16B 1.48
2021-06-30 $50.24B $33.79B 1.49
2021-03-31 $54.50B $34.75B 1.57
2020-12-31 $45.75B $29.45B 1.55
2020-09-30 $45.45B $28.56B 1.59
2020-06-30 $46.76B $28.52B 1.64
2020-03-31 $41.26B $27.04B 1.53
2019-12-31 $39.03B $23.53B 1.66
2019-09-30 $39.50B $23.23B 1.70
2019-06-30 $37.81B $23.09B 1.64
2019-03-31 $36.61B $22.68B 1.61
2018-12-31 $34.32B $21.97B 1.56
2018-09-30 $37.11B $24.17B 1.54
2018-06-30 $37.37B $24.51B 1.53
2018-03-31 $36.97B $24.76B 1.49
2017-12-31 $36.26B $23.36B 1.55
2017-09-30 $36.97B $24.41B 1.52
2017-06-30 $37.13B $22.57B 1.65
2017-03-31 $37.98B $23.17B 1.64
2016-12-31 $34.32B $21.29B 1.61
2016-09-30 $32.92B $21.04B 1.57
2016-06-30 $32.96B $20.82B 1.58
2016-03-31 $32.97B $20.81B 1.58
2015-12-31 $30.86B $19.09B 1.62
2015-09-30 $31.54B $18.37B 1.72
2015-06-30 $33.20B $20.67B 1.61
2015-03-31 $34.74B $21.31B 1.63
2014-12-31 $31.95B $18.75B 1.70
2014-09-30 $32.23B $18.40B 1.75
2014-06-30 $32.43B $19.18B 1.69
2014-03-31 $31.81B $18.49B 1.72
2013-12-31 $29.75B $16.35B 1.82
2013-09-30 $29.60B $16.04B 1.85
2013-06-30 $28.90B $16.03B 1.80
2013-03-31 $28.66B $16.03B 1.79
2012-12-31 $29.35B $16.00B 1.84
2012-09-30 $29.64B $14.08B 2.11
2012-06-30 $28.47B $16.18B 1.76
2012-03-31 $27.54B $15.96B 1.73
2011-12-31 $27.10B $15.90B 1.70
2011-09-30 $27.55B $15.79B 1.75
2011-06-30 $26.76B $14.11B 1.90
2011-03-31 $26.82B $14.16B 1.89
2010-12-31 $26.14B $14.01B 1.87
2010-09-30 $26.94B $14.14B 1.91
2010-06-30 $26.08B $14.84B 1.76
2010-03-31 $27.12B $14.81B 1.83
2009-12-31 $28.07B $14.67B 1.91
2009-09-30 $25.36B $14.13B 1.80
2009-06-30 $25.00B $14.34B 1.74
2009-03-31 $12.48B $15.34B 0.81
Sector Industry Market Cap Revenue
Medical Medical Services $91.409B $177.011B
Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.784B 25.47
CVS Health (CVS) United States $84.718B 10.53
Cencora (COR) United States $54.879B 19.08
DiDi Global (DIDIY) China $20.661B 31.36
Natera (NTRA) United States $20.542B 0.00
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.150B 12.86
EUROFINS SCIENT (ERFSF) Luxembourg $11.973B 0.00
Doximity (DOCS) United States $11.050B 57.47
CochLear (CHEOY) Australia $10.944B 0.00
ICON (ICLR) Ireland $10.818B 10.06
Revvity (RVTY) United States $10.756B 18.51
Viatris (VTRS) United States $10.400B 3.54
Medpace Holdings (MEDP) United States $8.508B 22.60
Sonic Healthcare (SKHHY) Australia $8.280B 0.00
Avantor (AVTR) United States $8.191B 11.90
HealthEquity (HQY) United States $7.819B 38.47
Charles River Laboratories (CRL) United States $6.817B 13.36
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $3.982B 23.48
BrightSpring Health Services (BTSG) United States $3.976B 36.81
Sotera Health (SHC) United States $3.727B 21.18
Alignment Healthcare (ALHC) United States $2.991B 0.00
Surgery Partners (SGRY) United States $2.841B 32.59
Concentras Parent (CON) United States $2.743B 15.85
Organon (OGN) United States $2.264B 2.41
Premier (PINC) United States $2.106B 14.42
Ardent Health Partners (ARDT) United States $2.073B 8.85
Progyny (PGNY) United States $1.815B 39.98
GeneDx Holdings (WGS) United States $1.660B 64.99
GoodRx Holdings (GDRX) United States $1.657B 30.86
PACS (PACS) United States $1.590B 0.00
Pediatrix Medical (MD) United States $1.248B 9.50
Teladoc Health (TDOC) United States $1.247B 0.00
Agilon Health (AGL) United States $1.196B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.978B 0.00
CareDx (CDNA) United States $0.855B 13.36
AMN Healthcare Services Inc (AMN) United States $0.840B 7.89
Embecta (EMBC) United States $0.696B 4.71
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.667B 13.08
Enhabit (EHAB) United States $0.521B 42.83
Auna S.A (AUNA) Luxembourg $0.508B 13.45
InnovAge Holding (INNV) United States $0.491B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
LifeMD (LFMD) United States $0.375B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.352B 0.00
SBC Medicals (SBC) United States $0.345B 0.00
Beauty Health (SKIN) United States $0.234B 0.00
Oncology Institute (TOI) United States $0.212B 0.00
Performant Healthcare (PHLT) United States $0.195B 0.00
DocGo (DCGO) United States $0.143B 23.33
Basel Medical Group (BMGL) Singapore $0.088B 0.00
So-Young (SY) China $0.086B 0.00
Sera Prognostics (SERA) United States $0.084B 0.00
OncoCyte (OCX) United States $0.082B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.054B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
KindlyMD (KDLY) United States $0.023B 0.00
ModivCare (MODV) United States $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00